Network Lead Academic Participating Site Grant from the Roswell Cancer Inst.

罗斯威尔癌症研究所的网络领导学术参与站点资助。

• 批准号: 9031741
• 负责人: SHASHIKANT LELE
• 金额: $ 61.6万
• 依托单位: ROSWELL PARK CANCER INSTITUTE CORP
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-05-06 至 2019-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9031741
• 关键词: Area; Beds; Blood; Breast; Buffaloes; Canada; Cancer Biology; Cancer Center Support Grant; Cancer Hospital; Cancer Patient; Caring; Clinic; Clinic Activity; Clinical; Clinical Data; Clinical Research; Clinics and Hospitals; Comprehensive Cancer Center; Conduct Clinical Trials; Connecticut; County; Cutaneous; Data; Disease; Doctor of Philosophy; Educational process of instructing; Enrollment; Family; Floor; Flow Cytometry; Gamma Knife Radiosurgery; Geographic Locations; Grant; Head and Neck Cancer; Health; Health Professional; Heart; Hematologic Neoplasms; Hospitals; Housing; Human Resources; Image Cytometry; Infusion procedures; Institutes; Institution; Intensity-Modulated Radiotherapy; Investigational Drugs; Laboratories; Lead; Life; Linear Accelerator Radiotherapy Systems; Malignant - descriptor; Malignant Childhood Neoplasm; Malignant Neoplasms; Malignant neoplasm of brain; Marrow; Medical; Medicine; Mission; Molecular; Monitor; National Cancer Institute; New York; Nursing Staff; Oncologic Nursing; Oncology Nurse; Operative Surgical Procedures; Pathology; Patient Care; Patient advocacy; Patients; Patients' Rooms; Pediatric Oncology; Pennsylvania; Phase; Physicians' Offices; Population; Preparation; Prevention education; Protocols documentation; Quality of life; Radiation; Radiation Oncology; Radiology Specialty; Research; Research Personnel; Resource Sharing; Resources; Roswell Park Cancer Institute; Services; Site; Specialist; Specimen; Supervision; System; Techniques; Therapeutic; Therapeutic Human Experimentation; Thoracic Oncology; Time; Transplantation; anticancer research; authority; cancer prevention; cancer therapy; clinical care; design; experience; improved; inter-institutional; melanoma; metropolitan; multidisciplinary; novel therapeutics; oncology; oncology service; organizational structure; phase 3 study; prognostic; programs; sample collection; sarcoma; square foot; symposium; tomography

DESCRIPTION (provided by applicant): The Roswell Park Cancer Institute has had a long tradition of contributing to the national cooperative groups over many decades. Those contributions have been scientific, administrative, and participatory (over 1200 patients have been enrolled in cooperative group trials over the last 5 years). Contributions have been consistent and numerous over the years. This application summarizes the intent of its 4 Co-PIs (Dr. Levine/Dr. Adjei/Dr. Lele/Dr. Singh) and the membership of RPCI to sustain its commitment to the many strengths inherent to cooperative group research: therapeutic advances; a better understanding of the biology of cancer; cancer prevention; means to improve the quality of life of cancer patients; piloting of new drugs and radiology and radiation and surgical techniques; establishing the relevance of new cellular and molecular advances to the predictive, prognostic, and therapeutic approaches to patients; and the advancement of patient advocacy. Investigators at RPCI and its supporting staff fully recognize the essential importance of the timely and accurate submission of data and specimens to achieve these aims.

描述（由申请人提供）：罗斯韦尔公园癌症研究所有着悠久的传统，几十年来一直为国家合作团体做出贡献。这些贡献是科学的、管理的和参与性的（在过去5年中，超过1200名患者参加了合作组试验）。多年来，捐助一直不断，数量众多。此应用程序总结了其4个Co-PI的意图（Levine博士/Adjei博士/Lele博士/Singh博士）和RPCI成员继续致力于合作小组研究的许多固有优势：治疗进展;更好地了解癌症生物学;癌症预防;改善癌症患者生活质量的方法;新药物和放射学以及放射和外科技术的试点;建立新的细胞和分子进展与患者预测，预后和治疗方法的相关性;以及患者倡导的进步。RPCI的研究人员及其支持人员充分认识到及时准确地提交数据和标本以实现这些目标的重要性。